Quick Answer
XTL BIOPHARMACEUTICALS LTD reported Total Assets of $8.55 million for fiscal year 2024.
XTL BIOPHARMACEUTICALS LTD Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $8.55M | +46.4% |
| 2024 | $5.84M | +140.8% |
| 2023 | $2.43M | -42.0% |
| 2022 | $4.19M | -36.7% |
| 2021 | $6.62M | +1.8% |
| 2020 | $6.50M | -9.8% |
| 2019 | $7.21M | -15.9% |
| 2018 | $8.57M | +30.2% |
| 2017 | $6.59M | +118.3% |
| 2016 | $3.02M | — |
- XTL BIOPHARMACEUTICALS LTD showed an increase of +46.4% in Total Assets compared to the prior fiscal year.
- Over the 2016–2024 period, XTL BIOPHARMACEUTICALS LTD’s total assets has grown by 183.4% (from $3.02 million to $8.55 million).
- The most recent figure is from XTL BIOPHARMACEUTICALS LTD’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: